Outcomes in patients treated with taxane regimen after immune checkpoint inhibitors failure in advanced or metastatic non-small cell lung cancer

被引：0
|
作者：
Guillemois, S. [1 ]
Seegers, V. [2 ]
Molinier, O. [3 ]
Masson, P. [4 ]
Capitain, O. [5 ]
Bigot, F. [6 ]
机构：
[1] ICO Site Paul Papin, Dept Med Oncol, Angers, France
[2] ICO, Biometr Unit, St Herblain, France
[3] Ctr Hosp Mans, Dept Resp Dis, Le Mans, France
[4] Ctr Hosp Cholet, Pneumol, Cholet, France
[5] Ctr Paul Papin, Dept Med Oncol, Angers, France
[6] ICO Inst Cancerol Ouest Site Paul Papin, Dept Med Oncol, Angers, France
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.10.088
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
70P
引用
收藏
页码：S1402 / S1403
页数：2
相关论文
共 50 条
  • [21] Impact of concomitant medication on clinical outcomes in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: A retrospective study
    Miura, Kaho
    Sano, Yoshiyuki
    Niho, Seiji
    Kawasumi, Kenji
    Mochizuki, Nobuo
    Yoh, Kiyotaka
    Matsumoto, Shingo
    Zenke, Yoshitaka
    Ikeda, Takaya
    Nosaki, Kaname
    Kirita, Keisuke
    Udagawa, Hibiki
    Goto, Koichi
    Kawasaki, Toshikatsu
    Hanada, Kazuhiko
    THORACIC CANCER, 2021, 12 (13) : 1983 - 1994
  • [22] The effect of metformin or dipeptidyl peptidase 4 inhibitors on clinical outcomes in metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
    Yang, Jieun
    Kim, Se Hyun
    Jung, Eun Hee
    Kim, Sang-A
    Suh, Koung Jin
    Lee, Ji Yun
    Kim, Ji-Won
    Kim, Jin Won
    Lee, Jeong-Ok
    Kim, Yu Jung
    Lee, Keun-Wook
    Kim, Jee Hyun
    Bang, Soo-Mee
    Lee, Jong Seok
    THORACIC CANCER, 2023, 14 (01) : 52 - 60
  • [23] Safety of Palliative Radiotherapy and Immune Checkpoint Inhibitors in Patients with Metastatic Non-Small Cell Lung Cancer
    Tjong, M.
    Ragulojan, M.
    Poon, I.
    Cheng, S.
    Doherty, M.
    Ung, Y.
    Cheung, P.
    Cheema, P.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S667 - S668
  • [24] Immune checkpoint inhibitors in non-small cell lung cancer
    Eberhardt, Wilfried Ernst Erich
    ONKOLOGE, 2017, 23 (10): : 838 - 844
  • [25] Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Herzberg, Benjamin
    Campo, Meghan J.
    Gainor, Justin F.
    ONCOLOGIST, 2017, 22 (01): : 81 - 88
  • [26] Angiogenesis and Immune-Related Biomarkers in Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
    Grapsa, D.
    Papadopoulou, A.
    Kokkotou, E.
    Gaitanakis, S.
    Gkiozos, I.
    Charpidou, A.
    Syrigos, K.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S331 - S332
  • [27] Clinical Impact of Immune Checkpoint Inhibitors Following Platinum Chemotherapy in Advanced or Metastatic Non-small Cell Lung Cancer Patients
    Lee, S. C.
    Ji, H. W.
    Chun, S.
    Kim, C. Y.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S635 - S635
  • [28] Outcomes from local consolidative therapy and immune checkpoint inhibitors in metastatic non-small cell lung cancer
    Hong, L.
    Rinsurongkawong, W.
    Rinsurongkawong, V.
    Spelman, A. R.
    Lewis, J.
    Gandhi, S. J.
    Antonoff, M. B.
    Gibbons, D. L.
    Vaporciyan, A. A.
    Lee, J. J.
    Heymach, J. V.
    Zhang, J.
    Vokes, N. I.
    ANNALS OF ONCOLOGY, 2021, 32 : S1017 - S1018
  • [29] Checkpoint inhibitors in older patients with advanced non-small cell lung cancer
    Reale, Maria Lucia
    Romano, Gianpiero Diego
    Paolelli, Loretta
    Leo, Silvana
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 188
  • [30] Clinical pattern of failure after a durable response to immune checkpoint inhibitors in non-small cell lung cancer patients
    Ja Yoon Heo
    Shin Hye Yoo
    Koung Jin Suh
    Se Hyun Kim
    Yu Jung Kim
    Chan-Young Ock
    Miso Kim
    Bhumsuk Keam
    Tae Min Kim
    Dong-Wan Kim
    Dae Seog Heo
    Jong Seok Lee
    Scientific Reports, 11
12345